Category Health/Medical

Study identifies Unique Cells that may drive Lung Fibrosis

 Single-cell landscape of PF and control lungs.

A groundbreaking study published today and led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, identifies unique lung cells that may drive Idiopathic Pulmonary Fibrosis (IPF), a deadly lung disease that affects hundreds of thousands of Americans, and for which there is no cure.

This is one of the first comprehensive looks at lung cells using a technology called single-cell RNA sequencing. Instead of examining a mash-up of many cells from a tissue sample, single-cell sequencing allowed researchers in this study to closely examine the individual cells that make up the lungs; to identify their function, and ultimately understand the molecular changes that may be driving the disease.

Using this met...

Read More

How Good Gut Bacteria help Reduce the Risk for Heart Disease

The bacteria’s activity in the intestines reduces production of a chemical that has been linked to the development of clogged arteries.
Illustration: Shutterstock.com

Researchers identify a protein responsible for bacteria’s beneficial behavior. Scientists have discovered that one of the good bacteria found in the human gut has a benefit that has remained unrecognized until now: the potential to reduce the risk for heart disease.

The bacteria’s activity in the intestines reduces production of a chemical that has been linked to the development of clogged arteries. After it’s manufactured in the gut, the chemical enters the bloodstream and travels to the liver, where it is converted into its most harmful form.

The Ohio State University researchers have traced the bacteria’s behavi...

Read More

Engineered Killer Immune Cells Target Tumors and their Immunosuppressive Allies

D-L1 CAR haNKs demonstrated superior killing of murine HNSCC targets compared to haNKs.

Scientists have engineered natural killer immune cells that not only kill head and neck tumour cells in mice but also reduce the immune-suppressing myeloid cells that allow tumours to evade the immune response, according to a new study in eLife.

The engineered cell therapy could be used as an alternative approach for treating cancer in patients for whom previous immunotherapy based on the activation of T cells has failed. These findings are reported by researchers at the U.S. National Institutes of Health (NIH) in Bethesda, Maryland.

In recent years, treatments called T-cell therapy or CAR-T cell therapy have been approved to treat blood cancers, and many others are now in development for othe...

Read More

Age-related Impairments Reversed in Animal Model

With age the frequency of adipose tissue eosinophils decreases gradually. This leads to the production of inflammatory mediators, which promote age-related impairments (e.g. frailty and immunosenescence). Eosinophil cell transfers increase the frequency of these cells in adipose tissue and dampen age-related chronic low-grade inflammation. This results in systemic rejuvenation of the aged organism. © DBMR, University of Bern, D. Brigger

Frailty and immune decline are two main features of old age. Researchers now demonstrate in an animal model that these two age-related impairments can be halted and even partially reversed using a novel cell-based therapeutic approach.

Elderly people are more prone to infectious diseases as the function of their immune system continuously declines w...

Read More